Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Floracopeia is a U.S.-based botanical wellness company focused on essential oils, flower essences, skincare, and education in botanical medicine and grassroots healthcare. The business was founded by herbalist and acupuncturist David Crow and built around ethically sourced plant-based products and educational services. Its historical product portfolio included essential oils, flower essences, tinctures, aromatic products, and skincare, and the company now appears to emphasize consulting, education, and brand legacy rather than direct sale of its original product catalog. Floracopeia has been acquired by Anima Mundi, which has launched an essential oil line using Floracopeia's trusted distillers and continues the brand's sourcing ethos. The company is healthcare-adjacent rather than a drug-development biotech or pharma company, with activities centered on wellness, aromatherapy, and botanical medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Floracopeia.